Atorvastatin News

Atorvastatin and Celecoxib Synergistic Against Colon Cancer Cells

Atorvastatin and celecoxib synergistically induce cell cycle arrest and apoptosis in colon cancer cells, according to a report in the May 1st International Journal of Cancer.

Dr Reddy's launches Atocor-R in India

Pharmaceutical major Dr Reddy's Laboratories on Thursday announced the launch of a drug 'Atocor-R', a combination of Atorvastatin and Ramipril, used in the treatment of cardiavascular disease, in the domestic market.

Ranbaxy gets mixed verdict on Pfizer’s Lipitor in Australia

In a partial victory for Ranbaxy Laboratories in its patent litigation against Pfizer, an Australian court has ruled in favour of the Indian company in a case relating to Atorvastatin, the world’s largest selling...

Aggressive Cholesterol Control Benefits Bypass Patients

Clinical studies have suggested that intensive lowering of low-density lipoprotein (LDL) cholesterol, the 'bad' cholesterol, benefits certain groups of patients with chronic diseases, such as diabetes.

AMA Backs FDA Pre-Screening of Direct-to-Consumer TV Drug Ads

The American Medical Association, testifying before Congress, has endorsed the proposal that the FDA should review and approve all direct-to-consumer ads for new drugs before they are aired on television.

Displaying results 1 to 5 out of 74

1

2

3

4

5

6

7

Next >

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.